8-K filed Nov 4, 2026 at 16:22 ET
MetLife reported Q3 2026 adjusted EPS of $2.78, slightly above the $2.77 consensus, and net income of $2.4B ($3.67 per share) up 187% YoY. Adjusted earnings ex-notables were a record $2.85 per share, driven by higher variable investment income, broad-based volume growth and favorable underwriting. Adjusted PFOs ex-PRT grew 8% to $13.5B with growth in all six segments. The annual actuarial assumption review reduced adjusted earnings by $46M. The company returned ~$1B to shareholders via buybacks and dividends.